Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nuevolution applies for delisting

The recommended public cash offer by Amgen Inc. (“Amgen”) to the shareholders of Nuevolution AB (publ) (“Nuevolution”) to tender all their shares in Nuevolution to Amgen (the “Offer”) was declared unconditional and was completed by Amgen on 8 July 2019. As announced by Amgen, shares and warrants corresponding in aggregate to approximately 97.8% of the total number of shares and votes in Nuevolution (on a fully diluted basis) have been tendered to Amgen in the Offer and in the separate offer to the holders of warrants issued by Nuevolution. Amgen announced that it intends to request the

Another RescueRunner will be donated to the Swedish Sea Rescue Society (SSRS)

The Swedish Sea Rescue Society receives another donation for a RescueRunner.SRRS already have a large number of RescueRunners from before as they were the organisation that invented the RescueRunner from the very beginning. At the time when the RescueRunner was developed  SSRS saw a great need to extend their fleet with a smaller boat type that could reach shallow, rocky and challenging waters and areas where the largers sea rescue vessels could not go. The RescueRunner has ever since become a vital part of their fleet and an important contribution to the other boat types SSRS uses for

Ocean Yield ASA: Second quarter and first half year 2019 Report

Fornebu, 11th July 2019, Ocean Yield ASA (“Ocean Yield” or the “Company”) announces results for the second quarter and first half year ending 30th June 2019. Highlights · Declared dividend for Q2 2019 of USD 0.1910 per share. This is the 24th consecutive quarterly dividend. · EBITDA for Q2 2019 was USD 56.8 million and EBITDA adjusted for finance lease effects was USD 74.5 million. · Net profit after tax for Q2 2019 was USD 5.3 million. This includes an increase in the provision for decommissioning expenses related to the FPSO of USD 4.5 million. Net profit from vessels with

HIDDN – Further update recapitalisation

(Oslo, July 11th 2019): Reference is made to previous announcements made by Hiddn Solutions ASA (the “Company”) regarding its financial situation and restructuring efforts, including announcement July 3rd 2019 at 15:12 CEST).  As announced, the Company is insolvent. Notwithstanding this situation, the board considers that there are grounds to continue a process, safeguarding creditor interests, whereby it explores possibilities for the Company, which could also be in the shareholders’ interests. The board is still continuing discussions with third parties and will further consider

#19-975 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

Experience “The Spirit of Woodstock” in Germany!

Karlsruhe invites you to its festivals of summer 2019[Evolution_Of_Love_Copyright_ZKM_Peter_Weibel_and_Gabor_Kadi_2019] Spread your picnic blanket and relax in the palace gardens while enjoying the largest digital work of art in Europe: the SCHLOSSLICHTSPIELE (castle light show). Karlsruhe, the gateway to the Black Forest, almost feels like Woodstock when the city is transformed into a huge open-air stage. It’s no wonder that there’s so much going on outdoors: Karlsruhe is one of the warmest cities in Germany, boasting 1,800 hours of sunshine a year. Visitors from far and wide can expect

Major League Baseball Players Alumni Association Brings Legends for Youth Baseball Coaches Clinic Series to Fairfax, IA

Free coaches clinic to feature former MLB coach and manager Bruce KimmColorado Springs, Colo. – Local coaches will have an opportunity to learn from former big league stars at the Major League Baseball Players Alumni Association (MLBPAA) Legends for Youth Coaches Clinic Series on Sunday, July 14th, 2019. The free clinic features former Major League Baseball players who will instruct local coaches, parents, volunteers and students on proper fundamentals, drills and techniques of coaching and running a practice. Players attending* include former coach of the Cincinnati Reds, Pittsburgh

Catena invests an additional SEK 150 million at Sunnanå Logistics Position

Catena has today signed a lease with DHL Express and will be investing SEK 150 million at Sunnanå Logistics Position, just outside Malmö.11 July 2019, 4:00 p.m. CET  The fifth facility to be established by Catena in Sunnanå is an air cargo warehouse of a total 10,162 square metres. A ten-year lease agreement with an annual rent of approximately SEK 10.5 million has been signed with DHL Express, the world's leading supplier of international express deliveries.   “DHL Express’ choice of the Sunnanå Logistics Position, which is part of Greater Copenhagen, for its handling of air cargo

Results on the IMMray™ PanCan-d optimization study to be presented at PancreasFest 2019

The results showed ROC AUC-values of 0.97, 0.98 and 0.96 differentiating pancreatic cancer (PDAC) vs. non-PDAC but symptomatic individuals, healthy controls and type II diabetes, respectively. Data for non-PDAC symptomatic patients, as well as diabetic patients, are novel and not reported before in literature.LUND, SWEDEN - Immunovia AB (publ) (“Immunovia”) today announced that, following the breakthrough news that was announced in June (link to PR ), the additional, more detailed data of the optimization study will be presented at

University Hospital Tübingen delivers 1,000th fraction with its Elekta Unity MR-Linac

Demonstrates commitment to providing patients with personalized precision radiation medicine for multiple cancer indicationsTÜBINGEN, Germany – Less than one year after installing its Elekta Unity magnetic resonance radiation therapy (MR/RT) system, the team of clinicians at University Hospital Tübingen in Germany have delivered their 1,000th radiation therapy fraction to a patient receiving treatment for prostate cancer. Many radiation therapy regimens divide the total radiation dose into two or more smaller doses, known as fractions, which are delivered in separate treatment sessions. The

Kerstin af Jochnick – new ECB representative to the Supervisory Board

The Governing Council of the European Central Bank (ECB) has appointed Kerstin af Jochnick as ECB representative to the Supervisory Board of ECB Banking Supervision.“I am very pleased to have been entrusted with the task of becoming independent member of the Supervisory Board of ECB Banking Supervision. The ECB's supervision of the larger banks in Europe plays a very important role in creating stable financial markets,” says First Deputy Governor Kerstin af Jochnick. Kerstin af Jochnick will therefore leave her post as First Deputy Governor of the Riksbank. The General Council of the

OUTOTEC OYJ: Change in the holding of the company’s own shares on July 11, 2019

OUTOTEC OYJ   STOCK EXCHANGE RELEASE   July 11, 2019 at 4:00 PM OUTOTEC OYJ: Change in the holding of the company’s own shares on July 11, 2019 On July 11, 2019 a total of 5,080 Outotec shares (OTE1V) have been returned to Outotec Oyj. The return is related to the company’s long-term share-based incentive plan. After the return, Outotec holds a total of 1,271,628 own shares. For further information please contact: OUTOTEC Jari Ålgars, CFOTel. +358 20 529 211DISTRIBUTION:NASDAQ HelsinkiMain mediawww.outotec.com

Nordic Nanovector completes patient enrolment into Phase 1 trial of Betalutin® in diffuse large B-cell lymphoma (DLBCL)

Oslo, Norway, 11 July 2019 Nordic Nanovector ASA (OSE: NANO) announces that the final patient has been enrolled in the LYMRIT 37-05 clinical trial of Betalutin® (177Lu-satetraxetan-lilotomab) in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) not eligible for stem cell transplantation. The LYMRIT 37-05 study is a Phase 1 open-label, single-arm, dose-escalation study designed to assess the safety, tolerability, pharmacokinetic profile and preliminary anti-tumour activity of a single administration of Betalutin®. Patients were enrolled at clinical trial sites in

Nokian Tyres’ US Factory Produces First Test Tire

Nokian Tyres, July 11, 2019 – The company’s North American production facility remains on schedule to begin producing tires for commercial use in early 2020.Nokian Tyres has produced the first test tire at its factory in Dayton, Tennessee, USA. The first tire, a Nokian eNTYRE 2.0 in size 205/55R16, marks the beginning of trial production, as Nokian Tyres remains on schedule to start building tires for commercial sale in the early part of next year. The Dayton Factory  will serve as a catalyst for Nokian Tyres’ growth strategy in North America;

Skanska signs new tenant lease at 99M in Washington, D.C., USA

Skanska has signed a lease for 11 years with CommonGrounds Workplace for approximately 4,100 square meters at its 99M office development in Washington, D.C., USA. The flexible workplace provider will take occupancy in spring 2020. With this transaction, the office portion of the development project is now 76 percent leased.99M is an 11-story, 22,000-square-meter, LEED® Gold, Class-A office development in Washington, D.C.’s Capitol Riverfront. Skanska began construction in July 2015 and completed construction in the second quarter of 2018. Skanska is one of the leading development and

Redsense Medical comments on the Trump initiative - potential impact on Redsense's business

President Donald Trump will order a broad overhaul of the nation’s organ transplant and kidney dialysis systems Wednesday in an executive order designed to prolong lives and to save the government billions of dollars, according to people familiar with the plan.President Trump will outline proposals to keep people with kidney disease off dialysis longer and to make treatment less expensive, to encourage more live donation of kidneys and livers, and to force the 58 non-profits that collect transplant organs to improve their performance, people briefed on the plan said. The President also will

Successful presentation by Cereno at ISTH in Melbourne - wins the "Top Poster" award

Cereno Scientific AB has recently participated in the annual major scientific conference on thrombosis related diseases ISTH in Melbourne, Australia, where interest in Cereno's drug candidate CS1 was great. The company's co-founder Pia Larsson, PhD presented Cereno's abstract "A New Treatment for Thrombosis Prevention?" in the form of a poster that received the award "Top Poster Winner".– It is always rewarding to meet the world's leading scientists and companies in the field and present our research to key stakeholders. Winning the prize Top Poster is an acknowledgment that our research is

Invitation to presentation of Q-linea’s Interim Report Q2-2019 on July 18, 2019

Q-linea AB (publ) (Nasdaq Stockholm: QLINEA), to publish the company’s Interim Report for the period January – June 2019 on Thursday, July 18, 2019 at 07:30 a.m. CET. Q-linea invites to an audiocast with teleconference (in English) for investors, analysts and media on July 18, at 13:00 – 14:00 p.m CET. Jonas Jarvius, CEO, and Anders Lundin, CFO, to present Q-linea and comment on the Interim Report Report for the period January – June 2019 followed by a Q&A-session.   To participate, please call any of the following phone numbers from:Sweden: + 46 8 519 993 83UK: + 44 333 300

Half-yearly report, January – June 2019

Positive trend for cloud services and challenging quarter in Business Unit WestThe second quarter in brief · Revenues decreased by 7% to SEK 806 (868) million. The growth in local currencies was -8%. · Adjusted EBITA amounted to SEK 36.7 (54.8) million. Items affecting comparability amounting SEK -9.1 million refers to divestment of subsidiary. · Profit before tax decreased to SEK 22.3 (46.8) million. Adjusted for items affecting comparability profit before tax amounted to SEK 31.4 (46.8) million. · Profit after tax amounted to SEK 12.8 (35.2) million. · Profit per share

Q-FREE - TOLLING CONTRACT IN AUSTRALIA - 55 MNOK

Q-Free has been awarded a tolling contract in Australia. The contract has a value of approximately 55 MNOK and comprises roadside solutions as well as service and maintenance for one year. Most of the revenues will be booked in 2020.   More details will be disclosed during the second quarter presentation tomorrow. For further information, please contact: President & CEO, Håkon Volldal: +47 977 19 973 CFO, Tor Eirik Knutsen: +47 950 50 062   About Q-Free  Q-Free is a leading global supplier of ITS (Intelligent Transportation Systems) products and solutions. The company has

ALOGIC launches in the UK with two state of the art docking stations

ALOGIC, the Australian manufacturer of a range of high-quality PC and Mac peripheral equipment, has debuted in the UK with distributor Westcoast. Across a range of over 4,000 products, ALOGIC has carved out a reputation for elegant, design-led hardware that still delivers on the levels of functionality and reliability expected by customers, with a two-year warranty across the board and 24 hour phone support available. This ethos is the perfect match for the service-led approach of Westcoast and brings pan European availability to the ALOGIC product range. ALOGIC’S arrival in the UK

Leading US proton center selects RayStation for treatment planning

The James M. Slater, MD Proton Treatment and Research Center at Loma Linda University Medical Center, US, has chosen the treatment planning system (TPS) RayStation®* to replace its existing systems for photon and proton therapy planning, following a tender process.The James M. Slater, MD Proton Treatment and Research Center is a cutting-edge facility that focuses on using advanced technology to deliver the best possible patient care. The center has treated more than 17,500 proton patients, more than any other facility in the world. To support the center's ongoing mission of providing the

There are no items matching the current filter
There are no more items matching the current filter
Back to top